Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis

A legfontosabb adatok

Ki végzi
University of Alberta
Hol
Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
125 fő, tervezett
Kezdés
2025. aug. 13.
Várható befejezés
2027. dec. 1.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Pharmacy-Physiotherapy Intervention
A regiszteradat frissítve
2026. október 27.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults aged 50 or older who have had pain, aching or stiffness in or around the knee for at least 1 month. It tests care shared by pharmacists and physiotherapists for early knee osteoarthritis.

Életkor
50 Years and older
Nem
All sexes
A betegség stádiuma
Early knee osteoarthritis: regular knee pain, aching or stiffness for at least 1 month. People must complete the screening PhIT-OA questionnaire.
Korábbi kezelés
Cannot join after a total knee replacement, knee surgery in the past 4 months, a knee joint injection in the past 3 months, or the GLA:D Hip and Knee program. Cannot join if they ever took csDMARD, bDMARD, tsDMARD, immunosuppressive drugs, Allopurinol, febuxostat or Colchicine.

A részvétel fő kizáró okai

  • Had a total knee replacement or on the waitlist for one
  • Knee surgery in the past 4 months or acute knee injury in the past 6 months
  • Doctor-diagnosed inflammatory arthritis (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus, gout) or fibromyalgia
  • Ever had a sudden, very painful, hot, swollen joint
  • Cannot speak and read English, or cannot visit the partner physiotherapy clinic

A regiszter feltételei, szó szerint

Mind a 13 feltétel megnézéseKevesebb

Ki vehet részt

  • regularly experiencing pain, aching, or stiffness in and/or around the knee for at least 1 month
  • complete the screening PhIT-OA questionnaire

Ki nem vehet részt

  • Prior total knee replacement or on the waitlist to have your knee replaced
  • Knee surgery within the previous 4 months
  • History of acute injury to knee within previous 6 months
  • Previous physician-diagnosed inflammatory arthritis (including this list): Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Lupus, Gout
  • Received a knee joint injection in the past 3 months or have one scheduled in the next 3 months
  • History of the following medications: csDMARD or bDMARD or tsDMARD, Immunosuppressive, Allopurinol or febuxostat, Colchicine
  • Unable to speak and read English
  • Unwilling or unable to visit a physiotherapist at a community physiotherapy clinic (specifically the dates and times of the partnering physiotherapy clinic)
  • Physician diagnosed fibromyalgia
  • A sudden, severely painful, hot, swollen joint at any time in the past
  • Has completed the GLA:D Hip and Knee program at all in the past

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Osteoarthritis (OA) is a slowly progressive chronic condition that is associated with aging and is characterized as joint pain. Individuals with early-stage OA usually do not seek medical attention. If and when they do, patients more often present to a pharmacy for over-the-counter medications.

A teljes eredeti leírásKevesebb

The investigators want to leverage community pharmacists' accessibility and scope of practice to best support patients with early knee OA. Given there are no disease-modifying treatments for OA, treatment guidelines center on patient education, self-management, and exercise, with medications playing a supporting role. Self-management is an effective strategy that provides a solid foundation for managing this progressive chronic condition and health care professionals like physiotherapists and pharmacists can help with the development and application of these skills.

A vizsgálat 2 csoportja

  • Usual Care (Control) GroupNincs vizsgálati kezelés, összehasonlításként

    Pharmacists will provide a general educational pamphlet and will inform the primary care physician of patient participation and referral for further assessment of knee OA. Participants randomized to this group will be offered physiotherapy and/or pharmacy interventions (individual or GLA:D program 3 months after enrollment) and pharmacy options (comprehensive medication review). It will be explained to participants that usual care is 'conservative therapy'. Usual care participants will be eligible to opt in for a comprehensive medication review (pharmacist) and/or the physiotherapy sessions and will be evaluated at 9-months after enrollment.

  • Intervention GroupA vizsgált kezelés

    Pharmacists will provide comprehensive 1:1 patient care, including a SCHOLAR assessment and medication review, provide specific drug therapy recommendation(s) using shared decision making (SDM), and provide comprehensive patient education/resources. Pharmacists will refer to physiotherapy clinics located nearby for patient convenience and to establish community pharmacy/physiotherapy clinic relationships. Participants will be offered a physiotherapy assessment at a nearby physiotherapy clinic within 2 weeks of being assessed by the pharmacist. After the physiotherapy assessment session, participants who are diagnosed with symptomatic knee OA will be offered the GLA:D program for knee OA which includes 6-weeks of neuromuscular exercises along with 2 education session in a group format.

    Kezelés: Pharmacy-Physiotherapy Intervention

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. október 27.